Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aliaga PT"'
Autor:
Corvaja C; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti, 435 - 20141 Milan, Italy., Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti, 435 - 20141 Milan, Italy. Electronic address: Antonio.Passaro@ieo.it., Attili I; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti, 435 - 20141 Milan, Italy., Aliaga PT; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti, 435 - 20141 Milan, Italy., Spitaleri G; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti, 435 - 20141 Milan, Italy., Signore ED; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti, 435 - 20141 Milan, Italy., de Marinis F; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti, 435 - 20141 Milan, Italy.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2024 Nov; Vol. 130, pp. 102824. Date of Electronic Publication: 2024 Sep 04.
Autor:
Mazzarella L; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy.; Department of Experimental Oncology, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Giugliano F; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Nicolo E; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Esposito A; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Crimini E; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Tini G; Department of Experimental Oncology, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Uliano J; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Corti C; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., D'Amico P; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Aliaga PT; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Valenza C; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Repetto M; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Antonarelli G; Department of Experimental Oncology, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Ascione L; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Vivanet G; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Berton Giachetti P; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Minchella I; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Belli C; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Locatelli M; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Criscitiello C; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy., Curigliano G; Early Drug Development for Innovative Therapies Division, IRCCS IEO - Istituto Europeo di Oncologia, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Publikováno v:
The oncologist [Oncologist] 2024 Feb 02; Vol. 29 (2), pp. e266-e274.
Autor:
Trapani D; Division of New Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy. Dario.Trapani@ieo.it., Sandoval J; Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.; Unit of Population Epidemiology, Division and Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland., Aliaga PT; Division of New Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hematology, University of Milan, Milan, Italy., Ascione L; Division of New Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hematology, University of Milan, Milan, Italy., Maria Berton Giachetti PP; Division of New Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hematology, University of Milan, Milan, Italy., Curigliano G; Division of New Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hematology, University of Milan, Milan, Italy., Ginsburg O; International Agency for Research On Cancer, Lyon, France.
Publikováno v:
Cancer treatment and research [Cancer Treat Res] 2023; Vol. 188, pp. 63-88.
Autor:
Giugliano F; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Zucali PA; Department of Oncology, IRCCS, Humanitas Clinical and Research Center, Via Manzoni 56, 20089, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele, Milan, Italy., Galli G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ballatore Z; Department of Medical Oncology, Università Politecnica Delle Marche, AOU Ospedali Riuniti di Ancona, Italy., Corti C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Aliaga PT; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy., Uliano J; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Vivanet G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Conforti F; Division of Medical Oncology for Melanoma, Sarcoma & Rare Tumours, European Institute of Oncology, IRCCS, Milan, Italy., Queirolo P; Division of Medical Oncology for Melanoma, Sarcoma & Rare Tumours, European Institute of Oncology, IRCCS, Milan, Italy., Berardi R; Department of Medical Oncology, Università Politecnica Delle Marche, AOU Ospedali Riuniti di Ancona, Italy., Manglaviti S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Apollonio G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Perrino M; Department of Oncology, IRCCS, Humanitas Clinical and Research Center, Via Manzoni 56, 20089, Rozzano, Milan, Italy., Borea F; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele, Milan, Italy., D'Antonio F; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele, Milan, Italy., Garassino MC; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Thoracic Oncology Program, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., De Pas T; Division of Medical Oncology for Melanoma, Sarcoma & Rare Tumours, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: Tommaso.depas@ieo.it.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 May; Vol. 166, pp. 202-207. Date of Electronic Publication: 2022 Feb 25.
Autor:
Montagna E; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: emilia.montagna@ieo.it., Bellerba F; Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Sangalli C; Data Management, European Institute of Oncology IRCCS, Milan, Italy., Gandini S; Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Cancello G; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Aliaga PT; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Galimberti V; Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Leonardi MC; Division of Radiotherapy, European Institute of Oncology IRCCS, Milan, Italy., Iorfida M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Munzone E; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Mazza M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Dellapasqua S; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Mastrilli F; Medical Administration, CMO, IEO, European Institute of Oncology IRCCS, Milan, Italy., Orecchia R; Scientific Direction, IEO, European Institute of Oncology IRCCS, Milan, Italy., Malengo D; Pharmacy, IEO, European Institute of Oncology IRCCS, Milan, Italy., Omodeo Salè E; Pharmacy, IEO, European Institute of Oncology IRCCS, Milan, Italy., Viale G; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy; University of Milan School of Medicine, Milan, Italy., Rietjens M; Division of Plastic and Reconstructive Surgery, European Institute of Oncology IRCCS, Milan, Italy., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Veronesi P; Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan School of Medicine, Milan, Italy.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2021 Oct; Vol. 47 (10), pp. 2694-2695. Date of Electronic Publication: 2021 May 25.